Frontiers in Endocrinology·26 SepExercise-responsive endocrine-metabolic mediators in diabetes and cardiometabolic disorders: a systematic scoping review and evidence mapSystematic reviewMechanismsPaper
BMJ Medicine·3 SepComparative efficacy and safety of glucagon-like peptide 1 based drugs for weight loss in adults with overweight or obesity without diabetes: network meta-analysis of randomised controlled trialsMeta-analysis of randomised trialsOverweightPaper
International Journal of Surgery·2 SepGlobal burden of liver cancer from 1990 to 2021 and 20-year projections: findings from the global burden of disease study 2021Computational studyPopulationsPaper
Frontiers in Endocrinology·6 AugOptimizing cardiovascular disease diagnosis through machine learning models integrating oxidized low-density lipoprotein and routine clinical indicatorsCohort study in peopleCardiovascular diseasePaper
ADA Scientific Sessions 2026 Abstract·5 JunSafety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IBI3032, a Novel Oral Nonpeptide GLP-1 Receptor Agonist: Single- and Multiple-Ascending Dose Studies in Chinese AdultsTrial in peopleInterventionsPaper